Meeting
2020 Genitourinary Cancers Symposium
Utilization of androgen deprivation therapy (ADT) and stereotactic body radiation therapy (SBRT) for localized prostate cancer (PC) in the United States (US).
Authors
Trevor Joseph Royce
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
Trevor Joseph Royce , Jeffrey M. Switchenko , Chao Zhang , Daniel Eidelberg Spratt , Ronald C. Chen , Ashesh B. Jani , Sagar Anil Patel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 370)
Abstract #
370
Poster Bd #
D2
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Self-reported burden in patients with localized prostate cancer treated with stereotactic body radiation therapy (SBRT).
First Author: Abigail Pepin
Poster
2024 ASCO Genitourinary Cancers Symposium
Pretreatment colonoscopy impact on acute gastrointestinal (GI) toxicity following curative stereotactic body radiation therapy (SBRT) for localized prostate cancer.
First Author: Jonathan W. Lischalk
Poster
2024 ASCO Genitourinary Cancers Symposium
Relugolix versus leuprolide in combination with radiotherapy for localized prostate cancer (REVELUTION trial): An initial analysis of patient treatment preferences and quality of life.
First Author: Sagar A. Patel
Poster
2024 ASCO Genitourinary Cancers Symposium
Weight variation during androgen deprivation therapy in patients with localized prostate cancer: Data from two prospective randomized trials.
First Author: Abdenour Nabid